Enanta Pharmaceuticals | ENTA - Eps Utile Per Azione

Prezzo Delle Azioni
12.62
Cambio Giornaliero
0.11 0.88%
Mensile
-14.44%
Annuale
103.55%
Q1 Previsione
12.13

Fiscal Calendario Efettivo Consenso Precedente Data




Eps Cambiamento Data
AbbVie USD 2.71 0.85 2025-12
Amgen USD 5.29 0.35 2025-12
Anika Therapeutics USD 0.13 0.35 2025-12
Arrowhead Research USD 0.22 0.33 2025-12
AstraZeneca USD 2.12 0.26 2025-12
BioCryst Pharmaceuticals USD 1.17 1.1 2025-12
Biogen USD 1.99 2.82 2025-12
Bristol-Myers Squibb USD 1.26 0.37 2025-12
Enanta Pharmaceuticals USD -1.05 0.31 2024-12
Gilead Sciences USD 1.86 0.61 2025-12
GlaxoSmithKline GBP 0.26 0.29 2025-12
Halozyme Therapeutics USD -0.24 1.96 2025-12
Heron Therapeutics USD -0.02 0.02 2025-12
Immunic USD -0.24 0.03 2024-09
Incyte USD 1.8 0.46 2025-12
Insmed USD -1.54 0.21 2025-12
Ionis Pharmaceuticals USD -1.41 0.61 2025-12
J&J USD 2.46 0.34 2025-12
Karyopharm Therapeutics USD -0.15 0.11 2024-12
Ligand Pharmaceuticals USD 2.02 1.07 2025-12
Merck USD 2.04 0.54 2025-12
Neurocrine Biosciences USD 1.88 0.29 2025-12
Novartis USD 1.54 0.5 2025-12
Novavax USD 0.13 0.59 2025-12
Pfizer USD 0.66 0.21 2025-12
PTC Therapeutics USD -1.67 1.87 2025-12
Roche Holding CHF 8.37 2.95 2025-12
Sarepta Therapeutics USD -3.58 3.45 2025-12
Vertex Pharmaceuticals USD 5.03 0.23 2025-12